Nanostructured Drug Market Is Growing with the Increasing Prevalence of Chronic Diseases and Rowing Geriatric Population

 


One of the key application of nanotechnology is in medicine, nano-medicine ranges from the medical application such as nanoelectronic biosensors, nanomaterial, biological device, and biological machines. The application of nanotechnology for drug delivery offer the potential for targeted delivery and enhanced treatment with fewer side effects. Nanostructured drug delivery applications occur through the use of nanomaterials, making delivery systems from nanoscale molecules such as liposomes. The Food and Drug Administration (FDA) has already approved some nanotechnology-based products, and expects a significant increase in the use of nanoscale materials in drugs, devices, biologics, cosmetics, and food.

The aforementioned factors are expected to augment the growth of the Nanostructured Drug Market, worldwide. Nanostructured drugs are designed to reduce the side effects related to drugs as well as decrease its treatment and consumption costs. These drugs find applications in cardiovascular/physiology, consumption, anti-inflammatory/immunology, anti-infective, and others. Moreover, the growth of the nanostructured drug market is attributed to the increase in research and development and growing awareness among people about the benefits offered by them in terms of shelf-life, drug stability, dosage, and bioavailability. This in turn is expected to increase the demand for nanostructured drugs worldwide.

Growth of the Nanostructured Drug Market, in North America and the Asia Pacific, is driven by the increasing prevalence of chronic diseases and rowing geriatric population in these regions. The number of population susceptible to various chronic diseases is increasing rapidly in both regions. According to the Centers for Disease Control and Prevention (CDC), in 2018, around 51.8% of US adults had at least one chronic condition, and around 27.2% had multiple chronic conditions. Prevalence was highest among women, non-Hispanic white adults, adults aged 65 or older, and those living in rural areas.

Nanotechnology offers multiple benefits in treating chronic human diseases by site-specific, and target-oriented delivery of precise medicines. A nanostructured drug is the application of nanotechnology in the medicinal field that has the potential to significantly change the course of diagnostics and treatment of various life-threating diseases. Thus, governments and market players are increasingly investing for the development of safe and effective nanostructured drugs, driving the growth of the nanostructured drug market.

However, the major factors which may restrain the nanostructured drug market growth include the high cost of development and risks associated with nanostructured drugs. Nanotechnology has direct beneficial applications for medicine, but like all technologies it may have unintended effects that can adversely impact the human body.


Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides